Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225978-06-000015
Filing Date
2006-12-08
Accepted
2006-12-08 11:25:26
Documents
1
Period of Report
2006-12-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7352
  Complete submission text file 0001225978-06-000015.txt   9988
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1285 AVE OF THE AMERICAS 35TH FL. NEW YORK NY 10019
Business Address 1285 AVE OF THE AMERICAS 35TH FL. NEW YORK NY 10019 2125544158
SCO CAPITAL PARTNERS LLC (Reporting) CIK: 0001225978 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 061264596

Mailing Address C/O SCO CAPITAL PARTNERS LLC 1285 AVENUE OF THE AMERICAS 85TH FLOOR NEW YORK NY 10019
Business Address 212-554-4158
Rouhandeh Steven H (Reporting) CIK: 0001294343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 061264595